ASTRAZENECA SELECTS LOCATION FOR NEW GLOBAL R&D CENTRE AND CORPORATE HEADQUARTERS IN CAMBRIDGE, UK
Move brings AstraZeneca’s small molecule and MedImmune’s biologics research and development together at purpose-built facility on Cambridge Biomedical Campus18 June 2013 AstraZeneca today announced that its new UK-based global research and development centre and corporate headquarters will be located at the Cambridge Biomedical Campus on the southern outskirts of the city. By 2016, the new site will house a highly-skilled workforce of approximately 2,000. As announced on 18 March 2013